237 related articles for article (PubMed ID: 19304440)
21. A subset of pancreatic adenocarcinomas demonstrates coamplification of topoisomerase IIalpha and HER2/neu: use of immunolabeling and multicolor FISH for potential patient screening andtreatment.
Hansel DE; Ashfaq R; Rahman A; Wanzer D; Yeo CJ; Wilentz RE; Maitra A
Am J Clin Pathol; 2005 Jan; 123(1):28-35. PubMed ID: 15762277
[TBL] [Abstract][Full Text] [Related]
22. HER3 overexpression as an independent indicator of poor prognosis for patients with curatively resected pancreatic cancer.
Hirakawa T; Nakata B; Amano R; Kimura K; Shimizu S; Ohira G; Yamada N; Ohira M; Hirakawa K
Oncology; 2011; 81(3-4):192-8. PubMed ID: 22067729
[TBL] [Abstract][Full Text] [Related]
23. Correlation of immunohistochemically detected HER-2/neu (c-erbB-2) with histological stage and perineural invasion in pancreatic cancer.
Tamiolakis D; Venizelos I; Simopoulos C; Kotini A; Jivannakis T; Papadopoulos N
Hepatogastroenterology; 2004; 51(56):334-7. PubMed ID: 15086152
[TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of the immediate early response gene X-1 (IEX-1) expression in pancreatic cancer.
Sasada T; Azuma K; Hirai T; Hashida H; Kanai M; Yanagawa T; Takabayashi A
Ann Surg Oncol; 2008 Feb; 15(2):609-17. PubMed ID: 18026799
[TBL] [Abstract][Full Text] [Related]
25. Cyclooxygenase-2 expression correlates with poor prognosis in pancreatic cancer.
Juuti A; Louhimo J; Nordling S; Ristimäki A; Haglund C
J Clin Pathol; 2006 Apr; 59(4):382-6. PubMed ID: 16467169
[TBL] [Abstract][Full Text] [Related]
26. Amplification and overexpression of c-erbB-2, epidermal growth factor receptor, and c-met in biliary tract cancers.
Nakazawa K; Dobashi Y; Suzuki S; Fujii H; Takeda Y; Ooi A
J Pathol; 2005 Jul; 206(3):356-65. PubMed ID: 15892172
[TBL] [Abstract][Full Text] [Related]
27. Potential for HER-2/neu molecular targeted therapy for invasive bladder carcinoma: comparative study of immunohistochemistry and fluorescent in situ hybridization.
Matsubara H; Yamada Y; Naruse K; Nakamura K; Aoki S; Taki T; Tobiume M; Zennami K; Katsuda R; Honda N
Oncol Rep; 2008 Jan; 19(1):57-63. PubMed ID: 18097576
[TBL] [Abstract][Full Text] [Related]
28. Expression of the caudal-type homeodomain transcription factors CDX 1/2 and outcome in carcinomas of the ampulla of Vater.
Hansel DE; Maitra A; Lin JW; Goggins M; Argani P; Yeo CJ; Piantadosi S; Leach SD; Biankin AV
J Clin Oncol; 2005 Mar; 23(9):1811-8. PubMed ID: 15774774
[TBL] [Abstract][Full Text] [Related]
29. The erbB-3 gene in human pancreatic cancer.
Lemoine NR; Lobresco M; Leung H; Barton C; Hughes CM; Prigent SA; Gullick WJ; Klöppel G
J Pathol; 1992 Nov; 168(3):269-73. PubMed ID: 1361525
[TBL] [Abstract][Full Text] [Related]
30. Expression of MAP4K4 is associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma.
Liang JJ; Wang H; Rashid A; Tan TH; Hwang RF; Hamilton SR; Abbruzzese JL; Evans DB; Wang H
Clin Cancer Res; 2008 Nov; 14(21):7043-9. PubMed ID: 18981001
[TBL] [Abstract][Full Text] [Related]
31. Deregulation of 2 potassium channels in pancreas adenocarcinomas: implication of KV1.3 gene promoter methylation.
Brevet M; Fucks D; Chatelain D; Regimbeau JM; Delcenserie R; Sevestre H; Ouadid-Ahidouch H
Pancreas; 2009 Aug; 38(6):649-54. PubMed ID: 19465885
[TBL] [Abstract][Full Text] [Related]
32. Epidermal growth factor receptor expression in human pancreatic cancer: Significance for liver metastasis.
Tobita K; Kijima H; Dowaki S; Kashiwagi H; Ohtani Y; Oida Y; Yamazaki H; Nakamura M; Ueyama Y; Tanaka M; Inokuchi S; Makuuchi H
Int J Mol Med; 2003 Mar; 11(3):305-9. PubMed ID: 12579331
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of the nuclear receptor coactivator AIB1 (SRC-3) during progression of pancreatic adenocarcinoma.
Henke RT; Haddad BR; Kim SE; Rone JD; Mani A; Jessup JM; Wellstein A; Maitra A; Riegel AT
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6134-42. PubMed ID: 15448000
[TBL] [Abstract][Full Text] [Related]
34. Prognostic factors in gastric cancer.
Brien TP; Depowski PL; Sheehan CE; Ross JS; McKenna BJ
Mod Pathol; 1998 Sep; 11(9):870-7. PubMed ID: 9758367
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of immunohistochemical RhoA expression on survival in pancreatic ductal adenocarcinoma: a high-throughput analysis.
Dittert DD; Kielisch C; Alldinger I; Zietz C; Meyer W; Dobrowolski F; Saeger HD; Baretton GB
Hum Pathol; 2008 Jul; 39(7):1002-10. PubMed ID: 18495213
[TBL] [Abstract][Full Text] [Related]
36. High epidermal growth factor receptor expression in metastatic colorectal cancer lymph nodes may be more prognostic of poor survival than in primary tumor.
Deng Y; Kurland BF; Wang J; Bi J; Li W; Rao S; Lan P; Lin T; Lin E
Am J Clin Oncol; 2009 Jun; 32(3):245-52. PubMed ID: 19451802
[TBL] [Abstract][Full Text] [Related]
37. Low-level expression of Smad7 correlates with lymph node metastasis and poor prognosis in patients with pancreatic cancer.
Wang P; Fan J; Chen Z; Meng ZQ; Luo JM; Lin JH; Zhou ZH; Chen H; Wang K; Xu ZD; Liu LM
Ann Surg Oncol; 2009 Apr; 16(4):826-35. PubMed ID: 19165547
[TBL] [Abstract][Full Text] [Related]
38. Peritumoral fibroblast SPARC expression and patient outcome with resectable pancreatic adenocarcinoma.
Infante JR; Matsubayashi H; Sato N; Tonascia J; Klein AP; Riall TA; Yeo C; Iacobuzio-Donahue C; Goggins M
J Clin Oncol; 2007 Jan; 25(3):319-25. PubMed ID: 17235047
[TBL] [Abstract][Full Text] [Related]
39. c-MYC activation in primary and metastatic ductal adenocarcinoma of the pancreas: incidence, mechanisms, and clinical significance.
Schleger C; Verbeke C; Hildenbrand R; Zentgraf H; Bleyl U
Mod Pathol; 2002 Apr; 15(4):462-9. PubMed ID: 11950922
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of EGFR and absence of C-KIT expression correlate with poor prognosis in salivary gland carcinomas.
Ettl T; Schwarz S; Kleinsasser N; Hartmann A; Reichert TE; Driemel O
Histopathology; 2008 Nov; 53(5):567-77. PubMed ID: 18983466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]